CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


11-August-2015
Cerilliant Introduces New Multi-component Solution Mixes for Drug Interference Testing

Interference Mix 4, 5-100 I-026
5-100 µg/mL of each component in Methanol

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs alprazolam; cimetidine; citalopram HBr; clonazepam; clopidogrel bisulfate; dextromethorphan; fluconazole; hydrochlorothiazide; lamotrigine; L-thyroxine; methylphenidate HCl; and omeprazole. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory's analytical methods.

Interference Mix 7, 50-100 I-029
50-100 µg/mL of each component in Methanol

This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory's analytical methods. This multi-component solution standard contains the routinely monitored over-the-counter (OTC) and prescription drugs montelukast sodium salt, pioglitazone hydrochloride, prednisolone, prednisone, procainamide HCl and simvastatin. 



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn